Dyne Therapeutics Inc (DYN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.22B
Last updated: Nov 17, 2026 at 11:05 AM ET
Dyne Therapeutics Inc (DYN) Earnings: Report Dates and Results
Dyne Therapeutics (DYN) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Dyne Therapeutics reported EPS of -$1.06, below the -$0.88 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DYN has an expected report date of Mar 1, 2027.
Earnings History
Of the 30 quarters below that had an estimate, DYN beat 11 and missed 19. The widest gap in the table came in the quarter ended Sep 30, 2016, when EPS landed 242.86% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.06 | -$0.88 | -$1.09 - -$0.65 | -20.45% | Miss | N/A | 14 | 1 up, 1 down | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$1.08 | -$0.74 | -$0.84 - -$0.62 | -45.95% | Miss | N/A | 14 | 5 up, 5 down | Jul 27, 2026 | N/A |
| Mar 31, 2026 | -$0.73 | -$0.78 | -$1.08 - -$0.64 | +6.41% | Beat | N/A | 10 | 5 up, 1 down | May 11, 2026 | N/A |
| Dec 31, 2025 | -$0.73 | -$0.77 | -$0.94 - -$0.59 | +5.48% | Beat | N/A | 10 | 1 up, 0 down | Mar 2, 2026 | N/A |
| Sep 30, 2025 | -$0.76 | -$0.81 | -$1.14 - -$0.64 | +6.17% | Beat | N/A | 11 | 1 up, 0 down | Nov 5, 2025 | N/A |
| Jun 30, 2025 | -$0.97 | -$0.93 | -$1.14 - -$0.62 | -4.30% | Miss | N/A | 13 | 1 up, 1 down | Jul 28, 2025 | N/A |
| Mar 31, 2025 | -$1.05 | -$0.84 | -$1.07 - -$0.52 | -25.00% | Miss | N/A | 10 | 2 up, 4 down | May 8, 2025 | N/A |
| Dec 31, 2024 | -$0.88 | -$0.91 | -$1.23 - -$0.67 | +3.51% | Beat | N/A | 9 | 0 up, 5 down | Feb 27, 2025 | $1.57M |
| Sep 30, 2024 | -$0.96 | -$0.71 | -$0.80 - -$0.61 | -35.21% | Miss | N/A | 10 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$0.70 | -$0.72 | -$0.97 - -$0.59 | +2.78% | Beat | N/A | 10 | 0 up, 0 down | Aug 12, 2024 | N/A |
| Mar 31, 2024 | -$0.81 | -$0.80 | -$0.83 - -$0.75 | -1.25% | Miss | N/A | 7 | 0 up, 0 down | May 2, 2024 | N/A |
| Dec 31, 2023 | -$1.09 | -$0.93 | -$1.08 - -$0.73 | -17.20% | Miss | N/A | 9 | 0 up, 0 down | Mar 5, 2024 | $3.79M |
| Sep 30, 2023 | -$0.99 | -$0.76 | -$1.17 - -$0.59 | -30.26% | Miss | N/A | 8 | 0 up, 0 down | Oct 30, 2023 | N/A |
| Jun 30, 2023 | -$1.08 | -$0.78 | -$0.91 - -$0.68 | -38.46% | Miss | N/A | 8 | 0 up, 0 down | Aug 3, 2023 | N/A |
| Mar 31, 2023 | -$0.78 | -$0.76 | -$0.87 - -$0.67 | -2.63% | Miss | N/A | 8 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$0.74 | -$0.84 | -$1.02 - -$0.67 | +11.90% | Beat | N/A | 8 | 0 up, 1 down | Mar 2, 2023 | N/A |
| Sep 30, 2022 | -$0.80 | -$0.92 | -$1.01 - -$0.78 | +13.04% | Beat | N/A | 6 | 0 up, 0 down | Nov 3, 2022 | N/A |
| Jun 30, 2022 | -$1.01 | -$0.80 | -$0.88 - -$0.69 | -26.25% | Miss | N/A | 6 | 0 up, 0 down | Aug 4, 2022 | N/A |
| Mar 31, 2022 | -$0.69 | -$0.88 | -$1.06 - -$0.74 | +21.59% | Beat | N/A | 4 | 0 up, 0 down | May 2, 2022 | N/A |
| Dec 31, 2021 | -$1.00 | -$0.97 | -$1.06 - -$0.86 | -3.09% | Miss | N/A | 4 | 0 up, 0 down | Mar 10, 2022 | N/A |
| Sep 30, 2021 | -$0.83 | -$0.66 | -$0.70 - -$0.61 | -25.76% | Miss | N/A | 4 | 0 up, 1 down | Nov 4, 2021 | N/A |
| Jun 30, 2021 | -$0.58 | -$0.55 | -$0.61 - -$0.50 | -5.45% | Miss | N/A | 4 | N/A | Aug 5, 2021 | N/A |
| Mar 31, 2021 | -$0.50 | -$0.62 | -$0.68 - -$0.54 | +19.35% | Beat | N/A | 5 | N/A | May 6, 2021 | N/A |
| Dec 31, 2020 | -$0.64 | -$0.37 | -$0.43 - -$0.32 | -72.97% | Miss | N/A | 5 | N/A | Mar 4, 2021 | N/A |
| Sep 30, 2020 | -$0.31 | -$0.39 | N/A | +20.51% | Beat | N/A | N/A | N/A | Nov 5, 2020 | N/A |
| Jun 30, 2020 | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 17, 2020 | N/A |
| Dec 31, 2017 | -$0.35 | -$0.42 | -$4.95 - $2.08 | +16.67% | Beat | N/A | 6 | N/A | Feb 22, 2018 | $470.00M |
| Sep 30, 2017 | $0.31 | $0.55 | $0.11 - $0.94 | -43.64% | Miss | N/A | 6 | N/A | Nov 1, 2017 | $182.00M |
| Jun 30, 2017 | -$1.12 | -$0.71 | -$1.33 - -$0.28 | -57.75% | Miss | N/A | 5 | N/A | Aug 4, 2017 | $181.00M |
| Mar 31, 2017 | -$1.24 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | May 5, 2017 | $175.00M |
| Dec 31, 2016 | -$1.40 | $0.14 | N/A | N/A | N/A | N/A | N/A | N/A | Feb 24, 2017 | $791.00M |
| Sep 30, 2016 | -$0.30 | $0.21 | N/A | -242.86% | Miss | N/A | N/A | N/A | Nov 2, 2016 | $241.00M |
| Jun 30, 2016 | -$1.36 | -$0.69 | N/A | -97.10% | Miss | N/A | N/A | N/A | Aug 4, 2016 | $166.00M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$3.51, after -$3.35 the year before. It was -$3.06 for the year ended Dec 31, 2016, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$3.51 | N/A |
| Dec 31, 2024 | -$3.35 | N/A |
| Dec 31, 2023 | -$3.94 | N/A |
| Dec 31, 2022 | -$3.24 | N/A |
| Dec 31, 2021 | -$2.91 | N/A |
| Dec 31, 2020 | -$1.34 | N/A |
| Dec 31, 2017 | -$2.40 | N/A |
| Dec 31, 2016 | -$3.06 | N/A |
Frequently Asked Questions About DYN
When is Dyne Therapeutics's next earnings date?
Dyne Therapeutics's next earnings report is expected for Mar 1, 2027.
Did DYN beat earnings estimates last quarter?
No. Dyne Therapeutics reported EPS of -$1.06 for the quarter ended Sep 30, 2026, below the -$0.88 estimate by 20.45%.
What EPS do analysts expect from DYN next quarter?
The consensus EPS estimate for Dyne Therapeutics for the quarter ending Dec 31, 2026 is -$0.99 from 17 analysts, with estimates from -$1.06 to -$0.89.
How often does DYN beat earnings estimates?
Dyne Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -9.27%.
DYN pages: Overview, Earnings, Forecast, Financials, Competitors